LEWISBERRY, Pa., Sept. 7 /PRNewswire/ -- Unilife Corporation (“Unilife” or “Company”) (Nasdaq: UNIS, ASX: UNS), today announced that its Chief Executive Officer, Alan Shortall, will be presenting at three upcoming investor conferences taking place in New York and Boston.
- On Monday, September 13, Mr. Shortall will present at the Rodman and Renshaw Annual Global Investment Conference in New York at 10:25 a.m. EDT.
- On Wednesday, September 15, Mr. Shortall will present at the Stifel Nicolaus Healthcare Conference in Boston at 8:35 a.m. EDT.
- On Monday, September 20, Mr. Shortall will present at the UBS Global Life Sciences Conference in New York at 4:00 p.m. EDT.
Each of the conference presentations will be broadcast over the Internet as a “live” listen only Webcast. To listen, please go to: http://ir.unilife.com/events.cfm. An archive of each event will also be available for those unable to listen live.
About Unilife Corporation
Unilife Corporation is a U.S.-based medical device company focused on the design, development, manufacture and supply of a proprietary range of retractable syringes. Primary target customers for Unilife products include pharmaceutical manufacturers, suppliers of medical equipment to healthcare facilities and patients who self-administer prescription medication. These patent-protected syringes incorporate automatic and fully-integrated safety features which are designed to protect those at risk of needlestick injuries and unsafe injection practices. Unilife is ISO 13485 certified and has FDA-registered medical device manufacturing facilities in Pennsylvania.
This press release contains forward-looking statements. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future are forward-looking statements. These forward-looking statements are based on management’s beliefs and assumptions and on information currently available to our management. Our management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. We do not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results, events and developments to differ materially from our historical experience and our present expectations or projections. These risks and uncertainties include, but are not limited to, those described in “Item 1A. Risk Factors” and elsewhere in our registration statement on Form 10 and those described from time to time in our periodic reports which we file with the Securities and Exchange Commission.
General: UNIS-G
Investor Contacts (US): | Investor Contacts (Australia) | ||
Todd Fromer / Garth Russell | Stuart Fine | Jeff Carter | |
KCSA Strategic Communications | Carpe DM Inc | Unilife Corporation | |
Phone +1 212-682-6300 | Phone +1 908-469-1788 | Phone + 61 2 8346 6500 | |
SOURCE Unilife Corporation